Application of Cucurmosin in preparation of medicaments for treating cervical cancer

A technology for cervical cancer and pumpkin is applied in the application field of pumpkin protein in the preparation of antitumor drugs, and can solve problems such as damage to normal tissues and cells.

Inactive Publication Date: 2011-05-04
FUJIAN MEDICAL UNIV +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Malignant tumors are diseases that seriously threaten human life and health. Chemotherapy drugs commonly used in clinical practice can greatly damage normal tissues and cells while killing tumor cells, which limits its application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Cucurmosin in preparation of medicaments for treating cervical cancer
  • Application of Cucurmosin in preparation of medicaments for treating cervical cancer
  • Application of Cucurmosin in preparation of medicaments for treating cervical cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] Example 1: Inhibitory effect of pumpkin protein on the proliferation of tumor cells cultured in vitro and its influence on human normal cells

[0012] Tumor cells in the logarithmic growth phase (gastric cancer cell SGC 7901 , HepG 2 、Bel 7404 , non-small cell lung cancer cell A 549 , breast cancer cells MCF-7 and melanoma cells B16) and normal human liver cells L02 were inoculated on a 96-well culture plate, and the inoculum volume per well was 3000-4000 cells / 100 μL and 6000 cells / 100 μL respectively; healthy blood donations were collected aseptically 15 mL of venous blood from patients, anticoagulated with heparin, separated mononuclear cells by Ficoll density gradient centrifugation, prepared single cell suspension with RPMI1640 containing 10% fetal bovine serum, and adjusted the cell concentration to 2×10 5 cells / mL, inoculated in 96-well culture plate, 100 μL per well. After 24 hours of cell culture on the above-mentioned culture plates, 100 μL of pumpkin prot...

Embodiment 2

[0015] Example 2: Pumpkin protein to SGC 7901 , HepG 2 、Bel 7404 、A 549 , MCF-7 and B16 cells inducing apoptosis

[0016] (1) Effect of pumpkin protein on the morphology of the above tumor cells

[0017] ①Fluorescence microscope observation: the above tumor cells were inoculated on multiple coverslips, treated with different concentrations of pumpkin protein for 24, 48 and 72 hours after 12 hours, and stained with acridine orange (AO) / ethidium bromide (EB) mixed fluorescent dyes Afterwards, place it upside down on a glass slide, and observe the morphological changes of the cells under a fluorescence microscope. Results: The above cells can be observed in the nucleus or cytoplasm of apoptotic cells in the early and middle stages, with densely stained granular yellow-green fluorescence, nuclear chromatin condensation, nuclear rupture, and the release of apoptotic bodies. Typical apoptotic cell morphology There are time- and dose-dependent changes in apoptosis.

[0018] ② E...

Embodiment 3

[0022] Example 3: Induction and differentiation of pumpkin protein on tumor cells (using melanoma B16 cells as a model)

[0023] (1) Observation of cell morphology: After the B16 cells in the control group and the experimental group were cultured for 72 hours, the cell morphology was observed and photographed with a phase contrast microscope and a transmission electron microscope, respectively. The result is as follows:

[0024] ①Observation by optical microscope: B16 cells in the control group grew irregularly in multiple layers, with overlapping round cells; after the treatment of pumpkin protein, the cells grew in a certain polarity, arranged in parallel without overlapping; after 3 days, the concentration of pumpkin protein was 2.5 For those above μg / mL, the polarity of the cells is obvious, most of the cells become larger, have a dendritic structure, the cells are connected into a network, grow slowly, and the number of cells decreases.

[0025] ② Electron microscope obser...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to application of Cucurmosin in preparation of medicaments. A ribosome-inactivating protein, namely the Cucurmosin can be separated out of pumpkin pulp, wherein the protein has high antitumor activity and can be used for preparing antitumor medicaments. The Cucurmosin can obviously inhibit gastric cancer cells SGC7901, hepatic cancer cells HepG2 and Bel74, non-small cell lung cancer cells A549, mammary cancer cells MCF-7 and melanoma cells B16 which are cultured in vitro, hardly inhibit human normal liver cells and peripheral blood lymphocytes, and shows obvious selectivity; and the Cucurmosin can also obviously inhibit animal-transplanted tumors such as cervical cancer U14, melanoma B16 and lung cancer Lewis and the like in mouse bodies. Besides, the invention also proves that the effects of inducing apoptosis and differentiation of tumor cells of the Cucurmosin are the important mechanism of the antitumor activity of the Cucurmosin.

Description

[0001] This application is a divisional application of the invention patent: application of pumpkin protein in pharmaceuticals (application date: November 3, 2005; application number: 200510119741.2). technical field [0002] The invention relates to the field of antitumor drugs, in particular to the application of pumpkin protein in the preparation of antitumor drugs. Background technique [0003] Malignant tumors are diseases that seriously threaten human life and health. Chemotherapy drugs commonly used in clinical practice can greatly damage normal tissues and cells while killing tumor cells, which limits its application. It has become the direction and urgent task of current anticancer drug research to find highly efficient and low toxic drugs for treating tumors. Finding anti-tumor drugs from natural substances has been considered an effective way, and the research on the anti-tumor effects of natural active substances, especially in the aspects of inhibiting prolifera...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/16A61P35/00A61P15/00
Inventor 谢捷明陈明晃
Owner FUJIAN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap